MR编号 | ES/V/0298/001 |
---|
药品名称 | Spasmipur 20 mg/ml |
---|
活性成分 | - Butacaine butylbromide 20.0 mg/ml
|
---|
剂型 | Solution for injection |
---|
上市许可持有人 | Richter Pharma AG |
---|
参考成员国 - 产品名称 | Spain (ES) |
---|
互认成员国 - 产品名称 | - Germany (DE)
- Denmark (DK)
Spasmipur Vet. - Belgium (BE)
Spasmipur 20 mg/ml - Netherlands (NL)
- Iceland (IS)
Spasmipur vet. 20 mg/ml stungulyf, lausn handa hestum, nautgripum, sauðfé og svínum - United Kingdom (Northern Ireland) (XI)
- Ireland (IE)
- Austria (AT)
Spasmipur 20 mg/ml Injektionslösung - France (FR)
SPASMIPUR SOLUTION INJECTABLE - Portugal (PT)
- Italy (IT)
- Greece (GR)
- Sweden (SE)
- Norway (NO)
Spasmipur vet - Finland (FI)
- Poland (PL)
- Latvia (LV)
- Lithuania (LT)
- Estonia (EE)
Spasmipur - Hungary (HU)
- Bulgaria (BG)
- Czechia (CZ)
Spasmipur 20 mg/ml injekční roztok - Romania (RO)
- Slovakia (SK)
- Slovenia (SI)
- Croatia (HR)
|
---|
许可日期 | 2019/02/06 |
---|
最近更新日期 | 2024/09/26 |
---|
药物ATC编码 | - QA03BB01 butylscopolamine
|
---|
申请类型 | - TypeLevel1:food
- TypeLevel2:Pharmaceutical
- TypeLevel3:Generic - art 13.2 Dir 2001/82/EC
- TypeLevel4:[not specified]
- TypeLevel5:[not specified]
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|